Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2009
05/20/2009CN100488540C Anti-obesity ingredients from medicinal plants and their composition
05/20/2009CN100488535C Lycopin mixture
05/20/2009CN100488526C Oral preparation
05/20/2009CN100488522C Application of epimeddium for preparing weight-reducing healthy product and medicinal preparation
05/20/2009CN100488513C Medicine for treating cerebrovascular and cardiovascular diseases and preparation process thereof
05/20/2009CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments
05/20/2009CN100488504C Novel coumarin-amide derivatives and its preparation, its drug composition and use
05/20/2009CN100488501C Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyper-permeability or undesired permeability
05/20/2009CN100488381C Propolis ganoderma lucidum spore, dried black fungus polysaccharide compounded soft capsule and preparing process therefor
05/19/2009US7534913 Crystalline form of nateglinide
05/19/2009US7534811 Cyclic onium compounds and glucosidase inhibitors
05/19/2009US7534808 Indolylmaleimide derivatives
05/19/2009US7534803 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis
05/19/2009US7534802 Compounds having 4-pyridylalkylthio group as substituent
05/19/2009US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives
05/19/2009US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia
05/19/2009US7534776 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
05/19/2009US7534770 extract of a plant of the family Liliaceae; Aloe vera; can be safely ingested without causing acute hypoglycemia and has a long-term blood glucose level control action to decrease the hemoglobin Alc level
05/19/2009US7534593 Crystals of glucokinase and methods of growing them
05/19/2009US7534440 Fusion molecules and methods for treatment of immune diseases
05/19/2009CA2468879C Substituted cyclohexane derivatives
05/19/2009CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them
05/19/2009CA2375017C Hydrochloride of fused-heterocycle compound
05/19/2009CA2367955C Abc1 polypeptide and methods and reagents for modulating cholesterol levels
05/14/2009WO2009062118A2 Modulation of protein trafficking
05/14/2009WO2009061498A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
05/14/2009WO2009061453A1 Solubilized thiazolopyridines
05/14/2009WO2009061445A2 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
05/14/2009WO2009060445A1 Synthetic sphingolipid analogs
05/14/2009WO2009060232A1 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465
05/14/2009WO2009060054A1 Triazole derivatives as scd inhibitors
05/14/2009WO2009060053A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
05/14/2009WO2009060024A1 Extract formulation of opuntia ficus indica
05/14/2009WO2009059943A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
05/14/2009WO2009059755A2 Novel neurturin conjugates for pharmaceutical use
05/14/2009WO2009059418A1 Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs
05/14/2009WO2009040083A3 Use of a peptide as a therapeutic agent
05/14/2009WO2009040047A3 Therapeutic uses of ghrelin and combinations with stresscopin
05/14/2009WO2009040033A3 Use of a peptide as a therapeutic agent
05/14/2009WO2009040019A3 Use of a peptide as a therapeutic agent
05/14/2009WO2009039986A3 Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-αrg as a therapeutic agent
05/14/2009WO2009033807A3 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43
05/14/2009WO2009033804A3 Use of gamma- endorphin as a therapeutic agent
05/14/2009WO2009033803A3 Use of the pentapeptide drlds and gamma-endorphin as therapeutic agents
05/14/2009WO2009033799A3 Use of a peptide as a therapeutic agent
05/14/2009WO2009033754A8 Use of a peptide as a therapeutic agent
05/14/2009WO2009021740A3 Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
05/14/2009WO2009013633A3 Amorphous coprecipitates of atorvastatin pharmaceutically acceptable salts
05/14/2009WO2008156869A3 Sirtuin modulating thiazolopyridine compounds
05/14/2009WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use
05/14/2009US20090124819 2-substituted vitamin d derivatives
05/14/2009US20090124691 Inhibitor of increase in postprandial blood insulin level
05/14/2009US20090124686 Gsk-3 inhibitors
05/14/2009US20090124684 Stimulation Of CPT-1 As A Means To Reduce Weight
05/14/2009US20090124682 Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity
05/14/2009US20090124674 Method for treating congestive heart failure
05/14/2009US20090124673 Method for treating diabetic nephropathy
05/14/2009US20090124671 Trpv1 antagonists
05/14/2009US20090124660 Piperidine Compounds Useful as Malonyl-CoA Decarboxylase Inhibitors
05/14/2009US20090124648 Such as trans-N-[1-(2-fluorophenyl)-S-pyrazoly]-3-ox-ospiro[6-azaisobenzofuran-1(3H),1'-cyclohexane]-4'-carboxamide and novel salts, hydrates and polymorphs thereof; neuropeptide y5 (NPY5)
05/14/2009US20090124638 Anti-inflammatory pyrazolopyrimidines
05/14/2009US20090124626 Pharmaceutical agent comprising insulin resistance improving agent
05/14/2009US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors
05/14/2009US20090124624 Substituted 1-aminophthalazine derivatives, preparation thereof and therapeutic application thereof
05/14/2009US20090124614 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
05/14/2009US20090124598 Pharmaceutical use of substituted amides
05/14/2009US20090124592 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
05/14/2009US20090124590 Pharmaceutical composition
05/14/2009US20090124589 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
05/14/2009US20090124572 Iron-containing nutritional supplement
05/14/2009US20090124559 Soft Protease Inhibitors and Pro-Soft Forms Thereof
05/14/2009US20090124551 Methods of administering bone health compositions derived from milk
05/14/2009US20090123582 Ameliorating Agent for Metabolic Syndrome
05/14/2009US20090123580 Methods for treating obesity, insulin resistance and inducing satiety
05/14/2009US20090123579 Method of promoting weight loss
05/14/2009US20090123563 Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand
05/14/2009US20090123530 Liposome Drug Delivery
05/14/2009US20090123524 Packaged satiety enhancing composition
05/14/2009US20090123455 Slimming cosmetic composition containing a substance inducing the production of il-6
05/14/2009DE60226044T2 Kristalline formen von fluvastatin-natrium Crystalline form of fluvastatin sodium
05/14/2009CA2742839A1 Novel neurturin conjugates for pharmaceutical use
05/14/2009CA2705303A1 Modulation of protein trafficking
05/14/2009CA2705138A1 Solubilized thiazolopyridines
05/14/2009CA2705113A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
05/14/2009CA2704663A1 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
05/14/2009CA2704640A1 Extract of fraxinus excelsior seeds and therapeutic applications therefor
05/14/2009CA2704633A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
05/14/2009CA2704222A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
05/14/2009CA2703781A1 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465
05/14/2009CA2703260A1 Method and compounds for modulating insulin production
05/13/2009EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport
05/13/2009EP2058320A1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
05/13/2009EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
05/13/2009EP2058311A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine
05/13/2009EP2058309A1 Fused heterocyclic compound
05/13/2009EP2058305A1 Urea derivative
05/13/2009EP2058008A1 Anti-obesity agent and use thereof
05/13/2009EP2057996A2 Y4 selective receptor agonists for therapeutic intervention
05/13/2009EP2057994A1 Prickly pear extract preparation
05/13/2009EP2057990A1 Lipid metabolism improving agent containing hydrogen molecule
1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 1298